Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice

Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice

Abstract Diabetic foot ulcers are a major health care concern with limited effective therapies. Mesenchymal stem cell (MSC)‐based therapies are promising treatment options due to their beneficial effects of immunomodulation, angiogenesis, and other paracrine effects. We investigated whether a bioeng...

Full description

Bibliographic Details
Main Authors: Hsin‐ya Yang, Fernando Fierro, Michelle So, Daniel J. Yoon, Alan Vu Nguyen, Anthony Gallegos, Michelle D. Bagood, Tomas Rojo‐Castro, Alan Alex, Heather Stewart, Marianne Chigbrow, Mohan R. Dasu, Thomas R. Peavy, Athena M. Soulika, Jan A. Nolta, R. Rivkah Isseroff
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Stem Cells Translational Medicine
Subjects:
animal models
diabetes
hypoxia
mesenchymal stem/stromal cells (MSCs)
Online Access:https://doi.org/10.1002/sctm.19-0380

Internet

https://doi.org/10.1002/sctm.19-0380

Similar Items